封面
市場調查報告書
商品編碼
1363034

生物製藥輔料市場規模、佔有率和趨勢分析報告:2023-2030 年按產品、地區和細分市場分類的趨勢

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizes & Surfactants/Emulsifiers, Carbohydrates, Specialty Excipients), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

生物製藥輔料市場成長與趨勢:

Grand View Research, Inc. 的最新報告顯示,到 2030 年,全球生物製藥輔料市場規模預計將達到 37.6 億美元。

預計2023年至2030年該市場將以5.50%的年複合成長率擴張。製藥公司對學名藥市場的日益關注、多功能賦形劑的日益採用以及生物活性物質的專利到期是推動市場成長的主要要素。此外,製造商的成本效率和能力、生物製藥的化學和物理不穩定性正在促進輔料的開發並推動市場。

近年來,生物相似藥的需求增加,導致生物製藥輔料的需求增加。專利到期、政府資助增加、患者人口統計和負擔能力上升等支持要素正在推動生物相似藥在世界各地的採用。此外,新興經濟體醫療保健基礎設施的快速發展增加了生物相似藥在生物相似藥生產中的使用。此外,全球範圍內引入更好的立法以確保生物相似藥有適當的法規和測試標準,這使得製造商更容易進入市場。

此外,工業界對多功能生物製藥輔料的接受度不斷提高也推動了市場的成長。多功能生物製藥輔料可高效能有效增強生物製藥製造製程。相關的好處包括提高產品品質、提高生產力和降低營運成本。 COVID-19 疫苗的成功高度依賴效率,而透過使用高效的藥物輸送系統可以提高效率。

市場主要參與者專注於新型生物製藥輔料的開發和行銷。例如,2021年4月,DFE Pharma推出了新的輔料產品線“BioHale”,以應對生物製藥公司的全球供應挑戰。此外,對生物製藥輔料不斷成長的需求正在增加生產設施的地理擴張。例如,2022年5月,DFE Pharma 在印度開設了一家新工廠,提供快速配方服務,包括輔料,幫助製藥公司實現正確的配方。

然而,生物製藥行業的供應鏈問題和生技藥品輔料市場開拓的挑戰預計將在預測期內阻礙市場。為生物製藥選擇合適的賦形劑是一項困難而複雜的挑戰,因為在一種製劑中有效的賦形劑可能會導致另一種製劑中的蛋白質分解或聚集。已知和核准的蛋白質穩定產品數量有限,進一步加劇了生物製藥製造商面臨的挑戰。因此,為了應對這些挑戰,研究人員正在開發新的創新方法。例如,為了維持脂質賦形劑(HMC賦形劑)的穩定性,研究人員應用了脂肪酸聚甘油酯(PGFA)。目前,在 COVID-19 疫苗的開發中,對這些產品的需求不斷增加。

生物製藥輔料市場報告亮點:

  • 碳水化合物產品領域在生物製藥輔料市場佔據主導地位,到 2022 年收益佔有率將達到 35.80%,預計這一趨勢將在預測期內持續下去。澱粉、蔗糖和葡萄糖在各種藥物製劑中的廣泛使用被認為是它們在這一領域佔據主導地位的要素。
  • 多元醇領域預計在預測期內年複合成長率5.77%。多元醇是存在於某些水果、蔬菜和無糖甜味劑中的糖醇。該領域的成長是由蛋白質治療藥物需求的增加所推動的。將多元醇添加到蛋白質配方中以增加張力和穩定性。
  • 按地區分類,2022年北美在生物製藥輔料市場中佔據最高佔有率。該地區的成長可歸因於多種要素,包括主要企業的存在、藥物開發的增加和人口眾多。該地區的公司經常合作開發生物製藥輔料。
  • 由於參與藥物開發的主要 CMO 的存在,預計亞太地區在預測期內將出現超過 6.0% 的快速成長。中國、印度和韓國等國大力參與生物相似藥的開發。生物相似藥在該地區廣泛開發有幾個原因,包括負擔能力、有利的法律規範、成本優勢和龐大的人口基數。例如,

目錄

第1章 生物製藥輔料市場:調查方法與範圍

第2章 生物製藥輔料市場:執行摘要

  • 市場預測
  • 產品簡介
  • 競爭形勢概覽

第3章 生物製藥輔料市場:市場變數、趨勢與範圍

  • 市場體系預測
  • 市場動態
  • 產業分析工具

第4章 生物製藥輔料市場:產品商業分析

  • 生物製藥輔料市場:產品變異分析
  • 增溶劑和介面活性劑/乳化劑
  • 多元醇
  • 碳水化合物
  • 特殊輔料

第5章 生物製藥輔料市場:區域商業分析

  • 區域市場概述
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第6章 生物製藥輔料市場:競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介

第7章 KOL推薦/分析師觀點

Product Code: GVR-3-68038-006-4

Biopharmaceutical Excipients Market Growth & Trends:

The global biopharmaceutical excipients market size is expected to reach USD 3.76 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 5.50% from 2023 to 2030. The increasing focus of pharmaceutical players on the generic market, rising adoption of multifunctional excipients, and patent expiry of biological actives are the key factors propelling market growth. Furthermore, the cost-efficiency & competency of manufacturers and the chemical and physical instability of biopharmaceuticals are boosting the development of excipients, thus propelling the market.

The demand for biosimilars has increased in recent years, which has in turn led to a rise in the demand for biopharmaceutical excipients. Supporting factors such as patent expirations, increasing government funding, patient demographics, and rising affordability have propelled the adoption of biosimilars across the globe. In addition, the rapidly evolving healthcare infrastructure in developing economies has increased their use in the production of biogenerics. Furthermore, the introduction of well-framed legislation to ensure proper regulatory and testing standards for biosimilars globally is set to ease market entry for manufacturers.

Moreover, the growing acceptance of multi-functional biopharmaceutical excipients in industries is also driving market growth. They are efficient and effective in enhancing the manufacturing process for biopharmaceuticals. Associated advantages include better product quality, improved productivity, and reduced operating costs. The success of COVID-19 vaccines majorly relies on their efficiency, which has been enhanced by using efficient drug delivery systems; this offers immense lucrative opportunities for market entities.

Key operating players in the market are focusing on the development and launch of novel biopharmaceutical excipients. For instance, in April 2021, DFE Pharma introduced a new excipient product line 'BioHale' to address global supply challenges for biopharmaceutical companies. Furthermore, the geographical expansion of manufacturing facilities is increasing, owing to the rising demand for biopharmaceutical excipients. For instance, in May 2022, DFE Pharma opened a new facility in India to offer fast-track formulation services, including excipients, for pharmaceutical players to achieve the right formulations.

However, issues pertaining to the supply chain in the biopharmaceutical industry and challenges in the development of excipients for biologics are expected to hamper the market during the forecast period. Selecting the right excipient for biopharmaceuticals is a challenging and complicated task, as an excipient effective in one formulation may cause degradation or aggregation of the protein in another. A limited number of known & approved products for the stabilization of protein further increases challenges for biopharma manufacturers. Hence, to deal with these challenges, researchers are developing new and innovative approaches. For instance, to maintain the stability of lipid-based excipients (HMC excipients), researchers have applied polyglycerol esters of fatty acids (PGFAs). Currently, these products are witnessing an increasing demand for the development of COVID-19 vaccines.

Biopharmaceutical Excipients Market Report Highlights:

  • Thecarbohydrate-based products segment dominated the market for biopharmaceutical excipients in 2022 with a revenue share of 35.80%, and this trend is expected to continue through the forecast period. The extensive use of starch, sucrose, and dextrose in various drug formulations can be primarily attributed to the dominant share of the segment
  • The polyols segment is expected to witness the fastest CAGR of 5.77% during the projection period. Polyols are sugar alcohols found in certain fruits, vegetables, and sugar-free sweeteners. The segment growth can be attributed to the increasing demand for protein therapeutics. Polyols are added in protein formulations for increasing tonicity and stability
  • In terms of region, North America held the highest share in the market for biopharmaceutical excipients in 2022.The regional growth can be attributed to several factors such as the presence of key players, increasing drug development, and a large population base. Companies in this region are collaborating frequently to develop biopharmaceutical excipients
  • In Asia Pacific, the market is expected to witness the fastest growth rate of over 6.0% during the forecast period, owing to the presence of large CMOs involved in drug development in the region. Countries such as China, India, and South Korea are majorly involved in the development of biosimilars. There are several reasons for the extensive development of biosimilars in this region, such as affordability, favorable regulatory framework, cost advantages, and the presence of a large population base

Table of Contents

Chapter 1 Biopharmaceutical Excipients Market: Research Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2 Biopharmaceutical Excipients Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Product Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Biopharmaceutical Excipients Market: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Chemical And Physical Instability Of Biopharmaceuticals Is Boosting The Development Of Excipients
      • 3.2.1.2 Increase In Focus Of Pharmaceutical Players On Biogeneric Market
      • 3.2.1.3 Cost Effective And Competency Of Manufacturers
      • 3.2.1.4 Patent Expiry Of Biological Actives
      • 3.2.1.5 Rising Adoption Of Multifunctional Excipients
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Challenges In Development Of Excipients For Biologics
      • 3.2.2.2 Issues Pertaining To Supply Chain In Biopharmaceutical Industry
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis

Chapter 4 Biopharmaceutical Excipients Market: Product Business Analysis

  • 4.1 Biopharmaceutical Excipients Market: Product Movement Analysis
  • 4.2 Solubilizes & Surfactants/Emulsifiers
    • 4.2.1 Solubilizes & Surfactants/Emulsifiers Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.2 Triglycerides
      • 4.2.2.1 Triglycerides Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.3 Esters
      • 4.2.3.1 Esters Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.4 Others
      • 4.2.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.3 Polyols
    • 4.3.1 Polyols Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.2 Mannitol
      • 4.3.2.1 Mannitol Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.3 Sorbitol
      • 4.3.3.1 Sorbitol Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.4 Others
      • 4.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.4 Carbohydrates
    • 4.4.1 Carbohydrates Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.2 Dextrose
      • 4.4.2.1 Dextrose Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.3 Sucrose
      • 4.4.3.1 Sucrose Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.4 Starch
      • 4.4.4.1 Starch Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.5 Others
      • 4.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.5 Specialty Excipients
    • 4.5.1 Specialty Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)

Chapter 5 Biopharmaceutical Excipients Market: Regional Business Analysis

  • 5.1 Regional Market Snapshot
  • 5.2 North America
    • 5.2.1 North America Biopharmaceutical Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.2.2.2 Key Country Dynamics
      • 5.2.2.3 Regulatory Framework
      • 5.2.2.4 Reimbursement Scenario
    • 5.2.3 Canada
      • 5.2.3.1 Canada Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.2.3.2 Key Country Dynamics
      • 5.2.3.3 Regulatory Framework
      • 5.2.3.4 Reimbursement Scenario
  • 5.3 Europe
    • 5.3.1 Europe Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.3.2 UK
      • 5.3.2.1 UK Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.2.2 Key Country Dynamics
      • 5.3.2.3 Regulatory Framework
      • 5.3.2.4 Reimbursement Scenario
    • 5.3.3 Germany
      • 5.3.3.1 Germany Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.3.2 Key Country Dynamics
      • 5.3.3.3 Regulatory Framework
      • 5.3.3.4 Reimbursement Scenario
    • 5.3.4 Spain
      • 5.3.4.1 Spain Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.4.2 Key Country Dynamics
      • 5.3.4.3 Regulatory Framework
      • 5.3.4.4 Reimbursement Scenario
    • 5.3.5 France
      • 5.3.5.1 France Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.5.2 Key Country Dynamics
      • 5.3.5.3 Regulatory Framework
      • 5.3.5.4 Reimbursement Scenario
    • 5.3.6 Italy
      • 5.3.6.1 Italy Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.6.2 Key Country Dynamics
      • 5.3.6.3 Regulatory Framework
      • 5.3.6.4 Reimbursement Scenario
    • 5.3.7 Denmark
      • 5.3.7.1 Denmark Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.7.2 Key Country Dynamics
      • 5.3.7.3 Regulatory Framework
      • 5.3.7.4 Reimbursement Scenario
    • 5.3.8 Sweden
      • 5.3.8.1 Sweden Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.8.2 Key Country Dynamics
      • 5.3.8.3 Regulatory Framework
      • 5.3.8.4 Reimbursement Scenario
    • 5.3.9 Norway
      • 5.3.9.1 Norway Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.9.2 Key Country Dynamics
      • 5.3.9.3 Regulatory Framework
      • 5.3.9.4 Reimbursement Scenario
  • 5.4 Asia Pacific
    • 5.4.1 Asia-Pacific Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.4.2 Japan
      • 5.4.2.1 Japan Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.2.2 Key Country Dynamics
      • 5.4.2.3 Regulatory Framework
      • 5.4.2.4 Reimbursement Scenario
    • 5.4.3 CHINA
      • 5.4.3.1 China Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.3.2 Key Country Dynamics
      • 5.4.3.3 Regulatory Framework
      • 5.4.3.4 Reimbursement Scenario
    • 5.4.4 India
      • 5.4.4.1 India Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.4.2 Key Country Dynamics
      • 5.4.4.3 Regulatory Framework
      • 5.4.4.4 Reimbursement Scenario
    • 5.4.5 South Korea
      • 5.4.5.1 South Korea Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.5.2 Key Country Dynamics
      • 5.4.5.3 Regulatory Framework
      • 5.4.5.4 Reimbursement Scenario
    • 5.4.6 Thailand
      • 5.4.6.1 Thailand Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.6.2 Key Country Dynamics
      • 5.4.6.3 Regulatory Framework
      • 5.4.6.4 Reimbursement Scenario
    • 5.4.7 Australia
      • 5.4.7.1 Australia Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.7.2 Key Country Dynamics
      • 5.4.7.3 Regulatory Framework
      • 5.4.7.4 Reimbursement Scenario
  • 5.5 Latin America
    • 5.5.1 Latin America Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.2.2 Key Country Dynamics
      • 5.5.2.3 Regulatory Framework
      • 5.5.2.4 Reimbursement Scenario
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.3.2 Key Country Dynamics
      • 5.5.3.3 Regulatory Framework
      • 5.5.2.4 Reimbursement Scenario
    • 5.5.4 Argentina
      • 5.5.4.1 Argentina Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.4.2 Key Country Dynamics
      • 5.5.4.3 Regulatory Framework
      • 5.5.4.4 Reimbursement Scenario
  • 5.6 MEA
    • 5.6.1 MEA Biopharmaceutical Excipients Market 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.2.2 Key Country Dynamics
      • 5.6.2.3 Regulatory Framework
      • 5.6.2.4 Reimbursement Scenario
    • 5.6.3 Saudi Arabia
      • 5.6.3.1 Saudi Arabia Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.3.2 Key Country Dynamics
      • 5.6.3.3 Regulatory Framework
      • 5.6.3.4 Reimbursement Scenario
    • 5.6.4 UAE
      • 5.6.4.1 UAE Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.4.2 Key Country Dynamics
      • 5.6.4.3 Regulatory Framework
      • 5.6.2.4 Reimbursement Scenario
    • 5.6.5 Kuwait
      • 5.6.5.1 Kuwait Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.5.2 Key Country Dynamics
      • 5.6.5.3 Regulatory Framework
      • 5.6.5.4 Reimbursement Scenario

Chapter 6 Biopharmaceutical Excipients Market: Competitive Landscape

  • 6.1 Company Categorization
  • 6.2 Strategy Mapping
    • 6.2.1 New product launch
    • 6.2.2 Partnerships
    • 6.2.3 Acquisition
    • 6.2.4 Collaboration
    • 6.2.5 Funding
  • 6.3 Company Market Share Analysis, 2022
  • 6.4 Company Profiles
    • 6.4.1 MERCK KGAA
      • 6.4.1.1 Company overview
      • 6.4.1.2 Financial performance
      • 6.4.1.3 Product benchmarking
      • 6.4.1.4 Strategic initiatives
    • 6.4.2 SIGNET EXCIPIENTS PVT. LTD.
      • 6.4.2.1 Company overview
      • 6.4.2.2 Financial performance
      • 6.4.2.3 Product benchmarking
      • 6.4.2.4 Strategic initiatives
    • 6.4.3 Sigachi Industries Pvt. Ltd
      • 6.4.3.1 Company overview
      • 6.4.3.2 Financial performance
      • 6.4.3.3 Product benchmarking
      • 6.4.3.4 Strategic initiatives
    • 6.4.4 ASSOCIATED BRITISH FOODS
      • 6.4.4.1 Company overview
      • 6.4.4.2 Financial performance
      • 6.4.4.3 Product benchmarking
      • 6.4.4.4 Strategic initiatives
    • 6.4.5 SPECTRUM CHEMICAL MANUFACTURING CORP.
      • 6.4.5.1 Company overview
      • 6.4.5.2 Financial performance
      • 6.4.5.3 Product benchmarking
      • 6.4.5.4 Strategic initiatives
    • 6.4.6 ROQUETTE FRERES
      • 6.4.6.1 Company overview
      • 6.4.6.2 Financial performance
      • 6.4.6.3 Product benchmarking
      • 6.4.6.4 Strategic initiatives
    • 6.4.7 DFE PHARMA
      • 6.4.7.1 Company overview
      • 6.4.7.2 Financial performance
      • 6.4.7.3 Product benchmarking
      • 6.4.7.4 Strategic initiatives
    • 6.4.8 CLARIANT
      • 6.4.8.1 Company overview
      • 6.4.8.2 Financial performance
      • 6.4.8.3 Product benchmarking
      • 6.4.8.4 Strategic initiatives
    • 6.4.9 COLORCON
      • 6.4.9.1 Company overview
      • 6.4.9.2 Financial performance
      • 6.4.9.4 Product benchmarking
      • 6.4.9.5 Strategic initiatives
    • 6.4.10 RETTENMAIER & SOHNE GMBH + CO KG
      • 6.4.10.1 Company overview
      • 6.4.10.2 Financial performance
      • 6.4.10.3 Product benchmarking
      • 6.4.10.4 Strategic initiatives
    • 6.4.11 BASF SE
      • 6.4.11.1 Company overview
      • 6.4.11.2 Financial performance
      • 6.4.11.3 Product benchmarking
      • 6.4.11.4 Strategic initiatives
    • 6.4.12 EVONIK INDUSTRIES AG
      • 6.4.12.1 Company overview
      • 6.4.12.2 Financial performance
      • 6.4.12.3 Product benchmarking
      • 6.4.12.4 Strategic initiatives
    • 6.4.13 IMCD
      • 6.4.12.1 Company overview
      • 6.4.12.2 Financial performance
      • 6.4.12.3 Product benchmarking
      • 6.4.12.4 Strategic initiatives

Chapter 7 KOL Recommendations/Analyst Perspective

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of top 10 drugs in 2020 by sales
  • TABLE 8 Chemically reactive oxidation products formed by use of Polysorbate 80
  • TABLE 9 The frequency of inclusion of polyols in mAb formulations (%)
  • TABLE 10 North America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 11 North America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 12 North America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 13 North America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 14 North America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 15 North America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 16 North America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 17 North America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 18 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 20 U.S. Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 21 U.S. Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 22 U.S. polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 23 U.S. polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 24 U.S. carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 25 U.S. carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 26 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 27 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 28 Canada Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Canada Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 30 Canada polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 31 Canada polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 32 Canada carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Canada carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 34 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 35 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 36 Europe Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 37 Europe Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 38 Europe polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 39 Europe polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 40 Europe carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 41 Europe carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 42 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 43 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 44 Germany Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 45 Germany Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 46 Germany polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 47 Germany polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 48 Germany carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 49 Germany carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 50 UK biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 51 UK biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 52 UK Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 53 UK Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 54 UK polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 55 UK polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 56 UK carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 57 UK carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 58 France biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 59 France biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 60 France Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 61 France Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 62 France polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 63 France polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 64 France carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 65 France carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 66 Italy biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 67 Italy biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 68 Italy Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 69 Italy Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 70 Italy polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 71 Italy polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 72 Italy carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 73 Italy carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 74 Spain biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 75 Spain biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 76 Spain Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 77 Spain Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 78 Spain polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 79 Spain polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 80 Spain carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 81 Spain carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 82 Denmark biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 83 Denmark biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 84 Denmark Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 85 Denmark Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 86 Denmark polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 87 Denmark polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 88 Denmark carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 89 Denmark carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 90 Sweden biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 91 Sweden biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 92 Sweden Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 93 Sweden Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 94 Sweden polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 95 Sweden polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 96 Sweden carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 97 Sweden carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 98 Norway biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 99 Norway biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 100 Norway Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 101 Norway Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 102 Norway polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 103 Norway polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 104 Norway carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 105 Norway carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 106 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 107 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 108 Asia Pacific Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 109 Asia Pacific Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 110 Asia Pacific polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 111 Asia Pacific polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 112 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 113 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 114 Top selling biopharmaceuticals in Japan: 2020
  • TABLE 115 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 116 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 117 Japan Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 118 Japan Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 119 Japan polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 120 Japan polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 121 Japan carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 122 Japan carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 123 China biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 124 China biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 125 China Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 126 China Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 127 China polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 128 China polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 129 China carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 130 China carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 131 India biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 132 India biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 133 India Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 134 India Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 135 India polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 136 India polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 137 India carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 138 India carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 139 Thailand biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 140 Thailand biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 141 Thailand Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 142 Thailand Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 143 Thailand polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 144 Thailand polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 145 Thailand carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 146 Thailand carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 147 South Korea: Approved Biosimilars
  • TABLE 148 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 149 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 150 South Korea Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 151 South Korea Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 152 South Korea polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 153 South Korea polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 154 South Korea carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 155 South Korea carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 156 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 157 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 158 Australia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 159 Australia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 160 Australia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 161 Australia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 162 Australia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 163 Australia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 164 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 165 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 166 Latin America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 167 Latin America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 168 Latin America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 169 Latin America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 170 Latin America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 171 Latin America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 172 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 173 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 174 Brazil Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 175 Brazil Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 176 Brazil polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 177 Brazil polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 178 Brazil carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 179 Brazil carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 180 Mexico biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 181 Mexico biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 182 Mexico Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 183 Mexico Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 184 Mexico polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 185 Mexico polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 186 Mexico carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 187 Mexico carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 188 Argentina biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 189 Argentina biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 190 Argentina Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 191 Argentina Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 192 Argentina polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 193 Argentina polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 194 Argentina carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 195 Argentina carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 196 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 197 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 198 Middle East & Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 199 Middle East & Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 200 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 201 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 202 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 203 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 204 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 205 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 206 South Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 207 South Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 208 South Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 209 South Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 210 South Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 211 South Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 212 Saudi Arabia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 213 Saudi Arabia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 214 Saudi Arabia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 215 Saudi Arabia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 216 Saudi Arabia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 217 Saudi Arabia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 218 Saudi Arabia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 219 Saudi Arabia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 220 UAE biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 221 UAE biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 222 UAE Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 223 UAE Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 224 UAE polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 225 UAE polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 226 UAE carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 227 UAE carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 228 Kuwait biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 229 Kuwait biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 230 Kuwait Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 231 Kuwait Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 232 Kuwait polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 233 Kuwait polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 234 Kuwait carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 235 Kuwait carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)

List of Figures

  • FIG. 1 Market snapshot
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Commodity flow analysis
  • FIG. 10 Volume price analysis
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market segmentation & scope
  • FIG. 13 Market driver relevance analysis (Current & future impact)
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for products, 2020
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic, and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global biopharma excipients market: Product outlook key takeaways
  • FIG. 19 Biopharma excipients market: Product movement analysis
  • FIG. 20 Global solubilizes & surfactants/emulsifiers market, by revenue 2018 - 2030 (USD Million)
  • FIG. 21 Global solubilizes & surfactants/emulsifiers market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 22 Global triglycerides market, by revenue 2018 - 2030 (USD Million)
  • FIG. 23 Global triglycerides market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 24 Global esters market, by revenue 2018 - 2030 (USD Million)
  • FIG. 25 Global esters market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 26 Global other Solubilizes market, by revenue 2018 - 2030 (USD Million)
  • FIG. 27 Global other Solubilizes market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 28 Global polyols market, by revenue 2018 - 2030 (USD Million)
  • FIG. 29 Global polyols market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 30 Global mannitol market, by revenue 2018 - 2030 (USD Million)
  • FIG. 31 Global mannitol market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 32 Global sorbitol market, by revenue 2018 - 2030 (USD Million)
  • FIG. 33 Global sorbitol market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 34 Global other polyols market, by revenue 2018 - 2030 (USD Million)
  • FIG. 35 Global other polyols market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 36 Global carbohydrates market, by revenue 2018 - 2030 (USD Million)
  • FIG. 37 Global carbohydrates market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 38 Global dextrose market, by revenue 2018 - 2030 (USD Million)
  • FIG. 39 Global dextrose market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 40 Global sucrose market, by revenue 2018 - 2030 (USD Million)
  • FIG. 41 Global sucrose market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 42 Global starch market, by revenue 2018 - 2030 (USD Million)
  • FIG. 43 Global starch market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 44 Global other carbohydrates market, by revenue 2018 - 2030 (USD Million)
  • FIG. 45 Global other carbohydrates market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 46 Global specialty excipients market, by revenue 2018 - 2030 (USD Million)
  • FIG. 47 Global specialty excipients market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 48 Regional market place: Key takeaway
  • FIG. 49 Biopharmaceutical excipients regional outlook, 2018 & 2030
  • FIG. 50 North America biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 51 U.S. biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 52 Canada biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 53 Europe biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 54 Germany biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 55 UK biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 56 France biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 57 Italy biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 58 Spain biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 59 Denmark biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 60 Sweden biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 61 Norway biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 62 Asia Pacific biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 63 Japan biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 64 China biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 65 India biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 66 Thailand biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 67 South Korea biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 68 Australia biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 69 Latin America biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 70 Brazil biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 71 Mexico biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 72 Argentina biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 73 Middle East & Africa biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 74 South Africa biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 75 Saudi Arabia biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 76 UAE biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 77 Kuwait biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 78 Strategy framework
  • FIG. 79 Participant categorization